Citadel Advisors’s Surrozen SRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-35,469
Closed -$1.03M 14793
2026
Q1
$1.03M Buy
35,469
+20,729
+141% +$497K ﹤0.01% 7589
2025
Q4
$333K Buy
14,740
+865
+6% +$14K ﹤0.01% 9911
2025
Q3
$179K Buy
13,875
+3,424
+33% +$35.9K ﹤0.01% 11379
2025
Q2
$93.4K Buy
+10,451
New +$95.5K ﹤0.01% 11397
2024
Q4
Sell
-10,930
Closed -$129K 15351
2024
Q3
$129K Buy
+10,930
New +$96.5K ﹤0.01% 10776
2022
Q1
Sell
-763
Closed -$74K 14528
2021
Q4
$74K Buy
+763
New +$86.5K ﹤0.01% 12995

Other funds holding SRZN

Citadel Advisors's SRZN Position: Q2 2026 in Review

Citadel Advisors sold out of Surrozen (SRZN) in Q2 2026, closing a stake of 35,469 shares — an estimated $1.03M sold.

Citadel Advisors first reported a position in SRZN in Q4 2021 and held it in 6 quarters. The position peaked at $1.03M in Q1 2026. 70 funds tracked by Wall St. Rank hold SRZN as of Q2 2026.

  • Citadel Advisors reported no remaining Surrozen position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 35,469 Surrozen shares in Q2 2026, an estimated $1.03M.
  • Citadel Advisors first reported a position in Surrozen in Q4 2021 and held it in 6 quarters.
  • Citadel Advisors's Surrozen position peaked at $1.03M in Q1 2026.
  • 70 funds tracked by Wall St. Rank held Surrozen as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.